Skip to main content

Peer Review reports

From: Levetiracetam for the treatment of mild cognitive impairment in Parkinson’s disease: a double-blind controlled proof-of-concept trial protocol

Original Submission
18 Sep 2022 Submitted Original manuscript
30 Sep 2022 Author responded Author comments - Nadeeka Dissanayaka
Resubmission - Version 2
30 Sep 2022 Submitted Manuscript version 2
14 Aug 2023 Reviewed Reviewer Report - Vida Bliokas
22 Aug 2023 Reviewed Reviewer Report - Sonu Bhaskar
25 Sep 2023 Author responded Author comments - Nadeeka Dissanayaka
Resubmission - Version 3
25 Sep 2023 Submitted Manuscript version 3
Publishing
16 Oct 2023 Editorially accepted
22 Nov 2023 Article published 10.1186/s40814-023-01406-y

You can find further information about peer review here.

Back to article page